Magazine article from our research archive:

Direct current cardioversion of atrial fibrillation--the next 40 years

Editorial

A trial fibrillation affects more than 2.5 million people in the United States. Almost 4 decades have passed since Lown et al1 first reported on successful direct current (DC) "cardioversion" of atrial fibrillation to sinus rhythm, thereby profoundly altering the treatment of the most common, sustained arrhythmia. Although restoration of sinus rhythm has been shown to provide symptomatic and physiologic benefits,2 it results in adverse events, including potentially catastrophic clinical thromboembolism in up to 6% of patients who are not receiving warfarin anticoagulation before cardioversion.3-5 Nonrandomized, relatively small series have suggested that 3 to 4 weeks of warfarin ...

Related newspaper, magazine, and journal articles:

See all results. Or, try our Advanced Search.

Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 60 million articles! Access over 3,500 publications with a FREE trial!